Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OH2 injection for first-line maintenance therapy in advanced colorectal cancer
CTR20223219Phase 2Terminated
- Sponsor
- Wuhan Binhui Biopharmaceutical Co., Ltd.
- Start
- Dec 2022
- Modality
- Oncolytic Viruses → Oncolytic Therapeutics, Vaccines & Immunotherapeutics, Gene Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of OH2 in colorectal adenocarcinoma, sponsored by Wuhan Binhui Biopharmaceutical Co., Ltd.. Started Dec 2022; status: terminated.
02
Drugs
OH2
03
Conditions
colorectal adenocarcinoma
Beyond the preview
Go deeper on CTR20223219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20223219.